Alphatec Holdings, Inc. (ATEC) Guidance & Earnings Results

On 2026-08-04 Alphatec Holdings, Inc. raised guidance: "FY2026 total revenue reaffirmed ~$882M ($805M surgical, $77M EOS); FY2026 adjusted EBITDA raised to ~$140M from ~$134M; FY2026 free cash flow at least…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ATECAlphatec Holdings, Inc.Follow ATEC — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 1.7B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
4 Aug 26	Raised	FY2026 total revenue reaffirmed ~$882M ($805M surgical, $77M EOS); FY2026 adjusted EBITDA raised to ~$140M from ~$134M; FY2026 free cash flow at least $20M · full year
5 May 26	Reaffirmed	Revenue ~$882M, adjusted EBITDA ~$134M · full year
24 Feb 26	Raised	FY2026 adjusted EBITDA guidance raised to ~$134M from $130M; revenue guidance ~$890M (+17% YoY).
12 Jan 26	Raised	2026 revenue guidance of $890M, up 17%
30 Oct 25	Raised	Revenue guidance raised from $742M to $760M; adjusted EBITDA guidance raised from $83M to $91M · full year
31 Jul 25	Raised	FY2025: total revenue raised to $742M from $734M; surgical revenue $666M; EOS revenue $76M; adjusted EBITDA raised to ~$83M from $78M. · full year

Alphatec Holdings, Inc. — questions

What guidance did Alphatec Holdings, Inc. give?: On 2026-08-04: "FY2026 total revenue reaffirmed ~$882M ($805M surgical, $77M EOS); FY2026 adjusted EBITDA raised to ~$140M from ~$134M; FY2026 free cash flow at least $20M"
When does Alphatec Holdings, Inc. report earnings?: Alphatec Holdings, Inc.'s next earnings report is expected on 2026-10-29.

Every figure on this page comes from Alphatec Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.